Markets
Is Atea Pharmaceuticals Inc. (NASDAQ:AVIR) Still Worth A Bite?
Atea Pharmaceuticals Inc. (NASDAQ:AVIR) Relative Strength Index (RSI) is 44.96, with weekly volatility at 9.51% and ATR at 1.91. The AVIR stock’s 52-week price range
Atea Pharmaceuticals Inc. (NASDAQ:AVIR) Relative Strength Index (RSI) is 44.96, with weekly volatility at 9.51% and ATR at 1.91. The AVIR stock’s 52-week price range
Atea Pharmaceuticals Inc. (NASDAQ:AVIR) shares traded lower over the last trading session, losing -0.97% on 06/15/21. The shares fell to a low of $22.74 before
Atea Pharmaceuticals Inc. (NASDAQ:AVIR) has a 12-month trailing P/E ratio of 92.92. The stock’s Relative Strength Index (RSI) is 44.35, with weekly volatility at 7.56%
Atea Pharmaceuticals Inc. (NASDAQ:AVIR) shares traded lower over the last trading session, losing -0.63% on 05/28/21. The shares fell to a low of $20.20 before
Atea Pharmaceuticals Inc. (NASDAQ:AVIR) shares fell to a low of $19.47 before closing at $19.52. Intraday shares traded counted 0.77 million, which was -8.23% lower
Discover high-quality information at your convenience with ‘State Reviewer.’ Our news portal offers valuable insights for free, available in accessible locations such as metro stations, busy intersections, cafes, and business centers. Wherever your day takes you, ‘State Reviewer’ ensures you’re never out of touch with the latest news and updates.
All rights reserved © 2024, Powered by Smart TechOne